SOTIO Biotech a.s clinical trials
SOTIO Biotech a.s is the lead sponsor of 4 current clinical trials in our USA, UK, France, Spain, Belgium, Czechia and EU (CTIS) registers. 1 is recruiting patients now. The most common phase is Phase 1/2. The most-studied condition is Hepatocellular Carcinoma.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by SOTIO Biotech a.s
3 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer
NCT07693751 · Colorectal Cancer (Locally Advanced or Metastatic)
|
Phase 1/2 | Recruiting | 2026-08 | USA |
|
A Study to Assess Safety and Efficacy of SOT201 in Patients With Advanced/Metastatic Cancer
NCT06163391 · Advanced Solid Tumor, Metastatic Solid Tumor
|
Phase 1 | Active, closed | 2024-05 | USA, France, Spain, Belgium, Czechia |
|
BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors
NCT05120271 · Hepatocellular Carcinoma, Squamous Cell Carcinoma of the Lung, Merkel Cell Carcinoma
|
Phase 1/2 | Active, closed | 2022-10 | UK, USA |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
SOTIO Biotech a.s in the EU trials register (CTIS)
1 trialAuthorised or ongoing trials in the EU Clinical Trials Information System with SOTIO Biotech a.s as sponsor. Some are the same study as a ClinicalTrials.gov record above; the two registries share no common ID. Trials with a site in Ireland are listed first.
| Study | Phase | Status | Countries |
|---|---|---|---|
|
A first-in-human phase 1/2 trial to evaluate the safety, pharmacokinetics, and preliminary efficacy of SOT109 in patients with advanced unresectable or metastatic colorectal cancer
2026-526235-19-00 · CTIS ↗ · Neoplasms
|
Phase 1 | Authorised | Czechia, Spain, France + 1 more |
Conditions in SOTIO Biotech a.s trials
7 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 3 | 1 |
| Clinical trials in UK | 1 | 0 |
| Clinical trials in France | 1 | 0 |
| Clinical trials in Spain | 1 | 0 |
| Clinical trials in Belgium | 1 | 0 |
| Clinical trials in Czechia | 1 | 0 |
| EU register (CTIS) | 1 | — |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Hepatocellular Carcinoma
Sponsors with the most current trials registered for this condition.
Questions about SOTIO Biotech a.s trials
How many clinical trials does SOTIO Biotech a.s sponsor?
SOTIO Biotech a.s is the lead sponsor of 3 current trials on ClinicalTrials.gov in our USA, UK, France, Spain, Belgium and Czechia registers, and 1 authorised or ongoing trial in the EU register (CTIS), as of the registry sync on 10 November 2026. Completed and withdrawn studies are not counted.
Are SOTIO Biotech a.s trials recruiting?
Yes. 1 of its 3 ClinicalTrials.gov trials is recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 10 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.